of problems, including crime, unemployment, racial justice, and human rights.
Controversy about alcoholism
Perhaps only slightly less heated was the recent controversy over the treatment of alcoholism, a condition affecting between nine and 15 million Americans, ranking among the chief causes of death, and costing society billions of dollars. Complete abstinence has long been the accepted treatment and the mainstay of Alcoholics Anonymous programmes. But in June of this year a report from the Rand Corporation, while not advocating that treated alcoholics should attempt normal drinking, noted that a substantial number have stabilised at what could be regarded as normal drinking levels. The report, supported by a grant from the National Institutes on Alcohol Abuse and Alcoholism, and based on a study of outcomes for persons treated in NIAAA-supported comprehensive alcoholism centres, found that while 70% of patients were improved, only relatively few were long-term abstainers; and in fact at 18 months there were roughly equal numbers of abstainers, periodic drinkers, and normal drinkers.
The authors were not mistaken in predicting that their findings "may be controversial in some quarters"; and the report was variously called a cruel hoax, dangerous, irresponsible, a disservice to society, more mischievous than worthy, clinically unsubstantiated, and methodologically unsound, with predictions that thousands will drink themselves to death. Some thought the study ignored the problem of physiological addiction; and some advocated withholding funds from this kind of research. Others, however, felt that the press had mishandled the report, that the reaction was largely emotional, and that repressing scientific data would have been unacceptable. Meanwhile, another study, this time from the Addiction Research Foundation in Toronto, added more fuel to the fire by also suggesting that some alcoholics could be helped by programmes stressing moderate drinking as the ultimate goal; so the last word on this issue remains to be written.
In conclusion, I refer to one more operation, unnecessary though trichological. It was reported from northwest Indiana that at least seven women shaved off their hair after a telephone call from a prankster who claimed to be a doctor at the local hospital. He told each woman that her husband had been admitted with convulsions caused by infectious disease, and that she should immediately shave off her hair to prevent further spread of the contagion. The hair was to be put in plastic bags and left for "someone from the lab" to pick up. It appears that no one from the lab ever came, and that the ladies, being beyond the help of conventional trichology, will have to be referred to the section of artificial organs.
Occasional Review
Use of cardiac pacemakers in Britain EDGAR SOWTON British MedicalJournal, 1976 , 2, 1182 -1184 The total cost of the generators used in 1975 was about £1 840 000, with a further £126 400 for electrodes, giving an approximate total cost of c2m for the implanted equipment alone.
Method of implantation
There was a definite preference for the initial implantation to be carried out with a transvenous electrode, and over 90% of patients were treated this way during 1973, 1974, and 1975 (the figures for all Britain were 900%, 92%_, and 91 %, and for Guy's Hospital 97O%, 95%, and 91%).
The reasons why some patients were treated with epicardial systems are not available for the whole country, but analysis of the Guy's Hospital series shows that epicardial electrodes were attached to the heart as a method of choice in 30 patients (5%) with heart block who were undergoing cardiac surgery for reasons such as aortic stenosis, but they were not otherwise used for the initial implant. 2 (3-3%) retired because of age, 1 (2%) retired early, and 2 (3 3%) were unable to find employment. Of the women, 13 (59%) were in paid employment and 9 (41 %), including housewives, were not. Overall, 60 patients (73%) were with the same employers as they were before a pacemaker was needed, and 52 of them (87%) were performing the same job. Six of these 60 (10%) had been given lighter duties but remained in essentially the same job, and 2 (3%) had been found a different job with their original employer. A further six patients had found new jobs with some difficulty (7% of the 82 replies), and 16 were not employed-in three cases owing to retirement. Overall, ofthe patients who wanted paid employment, all the women and 88% of men were able to obtain work. An implanted pacemaker was felt not to be a disadvantage in obtaining employment by 75% of the women and 62% of the men. A frequent comment was that jobs entailing heavy physical effort or lifting were unsuitable. Only one patient said that he was refused a job (at a bank) because of his pacemaker, and another found that declaring his pacemaker before an interview was disadvantageous, but this was not the case during the interview.
LEISURE ACTIVITIES About 80% of the patients were able to maintain or increase their level of activity during leisure compared with the period before pacing was needed. There was a tendency for the younger patients to become more active after implantation (table III) . Several patients were able to play tennis or golf or to enjoy sailing and hill-walking. Data are available on 86 patients, of whom 31 (36%) had not requested a licence. Of the 55 who attempted to obtain a licence 52 (94%) were successful. No difficulty had been experienced by 38 (69%), but 14 (25%) reported delays. Only one patient (included in the 38) did not disclose his pacemaker. One patient stopped driving voluntarily after having a pacemaker implanted, and two (4%) were refused licences after examination by the licensing authority. One patient was unable to renew his heavy goods vehicle licence but was granted a normal licence.
MOTOR INSURANCE
Sixteen companies provided data, and in total they insure some 10 million drivers. None had any knowledge of a claim involving someone with a pacemaker. In every case they require the pacemaker to be declared, both to the insurance company and to the licensing authority. Nine (56%) require an annual certificate from a cardiologist supporting the patient's application for insurance. Ten companies (63%) offer normal terms subject to a satisfactory medical report, two offer only restricted cover, and four impose an extra premium.
Of the 52 patients who obtained motor insurance 46 (88%) had no problems, five (10%) obtained cover with difficulty, and one did not declare his pacemaker. An additional premium of about 25% was paid by five patients (10%).
The insurance companies held different views about their likely action in the event of a claim involving a patient who had not disclosed his pacemaker. Without exception they confirmed that this would be adequate grounds for completely repudiating liability, but only six (37%) would probably do so. Seven companies (44%) would accept liability despite non-disclosure if the circumstances of the claim were not related to the pacemaker or if the patient's circumstances and medical condition would not have attracted an additional premium in any case. Three companies (19%) felt it was extremely unlikely they would ever exercise the option to repudiate liability.
Discussion
The number of initial implantations of cardiac pacemakers has almost trebled since 1972, when the British figure was 22/ million population. This is in keeping with the experience in many other countries, although it 
